Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 6, 2009

The Genome Center at Washington University Adds 21 Illumina Sequencers

  • The Genome Center at Washington University School of Medicine in St. Louis will acquire 21 Genome Analyzers from Illumina over the next several months to support the its expanding research initiatives.
     
    Once the scale-up is complete, the center will have an installed base of 35 Genome Analyzers. The Genome Center says that the added capacity will allow it to sequence about one human genome per day at 25 times coverage.


Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »